Funded Trials and Research Projects

We fund ideas that are ready for clinical studies and provide seed funding to help research projects move forward.

• Pilot Study of Biomarker Evaluation and Safety of Pre-Incisional Ketorolac for Patients Undergoing Surgical Resection for Non-Small Cell Lung Cancer and Renal Cell Carcinoma
  Principal Investigator: Viraj Master, MD, PhD

• Paricalcitol and hydroxychloroquine (PH) combination with gemcitabine and nab-paclitaxel in advanced pancreatic cancer
  Principal Investigator: Olatunji Alese, MD

• Propranolol Hydrochloride and Pembrolizumab in Patients with Recurrent or Metastatic Urothelial Carcinoma: A Single-Institute Phase II Trial
  Principal Investigator: Bassel Nazha, MD, MPH

• A Phase Ib/II Study of Propranolol with Fixed-dose Pembrolizumab in Patients with Unresectable Stage III and Stage IV Melanoma
  Principal Investigator: Melinda Yushak, MD, MPH; Collaborative Trial with Roswell Park

• A Randomized Window of Opportunity Study of Preoperative Letrozole and Simvastatin Versus Letrozole Alone in Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
  Principal Investigator: Ruth Sacks, MD

• Arginine Therapy in COVID-19: An Open-Label Prospective Pilot Study
  Principal Investigator: Claudia Morris, MD

• Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
  Principal Investigator: Namita Khanna, MD, MSPH

• Treatment of Brain Metastases with Arginine Supplementation
  Principal Investigator: Lisa Sudmeier, MD, MPH

• Prevention of Paclitaxel-Induced Peripheral Neuropathy with Cryotherapy With or Without Cilostazol
  Principal Investigator: Susan C. Modesitt, MD

• VA Pharmacoepidemiology Project
  We're collaborating with teams at Emory Winship Cancer Institute and the Atlanta VA Health Care System to leverage the scale of the VA's electronic health records system, which has access to several decades' worth of healthcare data from 22 million veterans. Research teams are conducting retrospective studies to investigate associations between medications and outcomes of cancer patients throughout the years.

Find a Complete list of Emory's Cancer Clinical Trials at the Winship Cancer Institute »

Morningside Center Research Awards

• Repurposing CD26/DPP4 inhibitors for immunotherapy of cancer
  Principal Investigator: Gregory Lesinski (SOM: Hematology and Medical Oncology)

• Indole-3-Carbinol Supplement for Prevention of Serious Acute Graft Versus Host Disease
  Principal Investigator: Edmund Waller (SOM: Medicine, Pathology, Hematology and Medical Oncology)

• Repurposing Statin Drugs to Enhance Immunotherapy in Head and Neck Cancer
  Principal Investigator: Nicole Schmitt (SOM: Otolaryngology)

• Repurposing Verteporfin for treatment of Pediatric High-grade Gliomas
  Principal Investigator: Renee Read (SOM: Pharmacology and Chemical Biology)

• Targeting patients with breast adipose tissue inflammation for statin therapy to prevent breast cancer recurrence
  Principal Investigator: Lauren McCullough (RSPH: Epidemiology)